menu
    • menu

    Company profile for Akston Biosciences

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Located in Beverly, Massachusetts, Akston Biosciences leverages its core expertise of designing novel fusion proteins to develop and manufacture new classes of biologic therapeutics for Type 1 diabetes (T1D) prevention, ultra-long acting insulin therapy, and vaccines. Founded by the team that developed the world’s first clinical glucose-responsive insulin at SmartCells, Inc. (sold to Merck & Co. in 2010), Akston has raised ...
    Located in Beverly, Massachusetts, Akston Biosciences leverages its core expertise of designing novel fusion proteins to develop and manufacture new classes of biologic therapeutics for Type 1 diabetes (T1D) prevention, ultra-long acting insulin therapy, and vaccines. Founded by the team that developed the world’s first clinical glucose-responsive insulin at SmartCells, Inc. (sold to Merck & Co. in 2010), Akston has raised over $18 million in equity financing from the management team and private investors, as well as $10 million from National Institutes of Health grants and The Helmsley Charitable Trust.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Akston BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Cummings Center​, Suite 454C Beverly, MA 01915
    Telephone
    Telephone
    978-969-3381
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.akstonbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Energesis And Akston Sign Partnership For Companion Animal Obesity Drug
    Energesis And Akston Sign Partnership For Companion Animal Obesity Drug

    20 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240820433433/en

    BUSINESSWIRE
    20 Aug 2024
    Share Share
    Purdue And Akston Partner For Dog Cancer Drug Development
    Purdue And Akston Partner For Dog Cancer Drug Development

    13 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240813235302/en

    BUSINESSWIRE
    13 Aug 2024
    Share Share
    Dechra Purchases Veterinary Insulin Programs from Akston Biosciences
    Dechra Purchases Veterinary Insulin Programs from Akston Biosciences

    30 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240730746315/en

    BUSINESSWIRE
    30 Jul 2024
    Share Share
    Akston's AKS-107 Study Published in Frontiers in Ambifect Platform’s Versatility
    Akston's AKS-107 Study Published in Frontiers in Ambifect Platform’s Versatility

    11 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240311971440/en

    BUSINESSWIRE
    11 Mar 2024
    Share Share
    Akston Biosciences to Focus on Strong Animal Health Pipeline
    Akston Biosciences to Focus on Strong Animal Health Pipeline

    17 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230817799089/en

    BUSINESSWIRE
    17 Aug 2023
    Share Share
    Akston Biosciences Ends Vaccine Partnership with Stelis
    Akston Biosciences Ends Vaccine Partnership with Stelis

    07 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230306005704/en

    BUSINESSWIRE
    07 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search